Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Apr 2;27(1):172-186.e7.
doi: 10.1016/j.celrep.2019.03.020.

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

Affiliations
Free article
Clinical Trial

Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans

Pramila Rijal et al. Cell Rep. .
Free article

Abstract

We describe therapeutic monoclonal antibodies isolated from human volunteers vaccinated with recombinant adenovirus expressing Ebola virus glycoprotein (EBOV GP) and boosted with modified vaccinia virus Ankara. Among 82 antibodies isolated from peripheral blood B cells, almost half neutralized GP pseudotyped influenza virus. The antibody response was diverse in gene usage and epitope recognition. Although close to germline in sequence, neutralizing antibodies with binding affinities in the nano- to pico-molar range, similar to "affinity matured" antibodies from convalescent donors, were found. They recognized the mucin-like domain, glycan cap, receptor binding region, and the base of the glycoprotein. A cross-reactive cocktail of four antibodies, targeting the latter three non-overlapping epitopes, given on day 3 of EBOV infection, completely protected guinea pigs. This study highlights the value of experimental vaccine trials as a rich source of therapeutic human monoclonal antibodies.

Keywords: E-S-FLU virus; Ebola virus; Ebola virus glycoprotein epitopes; affinity maturation; antibody binding kinetics; guinea pig model; human monoclonal antibodies; immunotherapy; therapeutic antibodies.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources